Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000176

Director sold 5,000 shares at an average $41.93 ($209,646)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
PARSHALL B LYNNE Director 2025-08-06 Sale 10b5-1 −4,600 $41.87 $192,595 86,744 D
PARSHALL B LYNNE Director 2025-08-06 Sale 10b5-1 −400 $42.63 $17,051 86,344 D
Open-market sales · 5,000 sh · avg $41.93 · $209,646
Loading xslF345X05/edgardoc.xml…